Skip to Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

20 March 2025

22 Pages

Individuals 45 Years and Older in Opioid Agonist Treatment: A Scoping Review

,
,
and
Department of Addiction Medicine, Haukeland University Hospital, 5009 Bergen, Norway
*
Author to whom correspondence should be addressed.

Abstract

This scoping review explores the unique challenges and needs faced by ageing individuals, aged 45 and above, in opioid agonist treatment (OAT), noting the earlier onset of age-related impairments among this population. The literature search was conducted in PsycINFO, EMBASE, MEDLINE, CINAHL, and Web of Science. A total of 28 observational studies were included. Five topics were identified: health, treatment, substance use, demographic, and social aspects. Findings reveal that, while health and age-related concerns are often discussed in the literature, limited attention has been given to gender differences, social factors such as financial issues, and psychological factors, which are also critical aspects of the lives of ageing individuals undergoing OAT. This review emphasizes the importance of expanding research to address these gaps, ultimately aiming to improve their overall well-being.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.